Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
Inhibrx Biosciences, Inc
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Blueprint Medicines Corporation
Amgen
Eli Lilly and Company
Actuate Therapeutics Inc.
Taiho Pharmaceutical Co., Ltd.
Innovent Biologics (Suzhou) Co. Ltd.
Eli Lilly and Company